Search Results

There are 4658 results for: content related to: Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2328–2337, William Stohl, Falk Hiepe, Kevin M. Latinis, Mathew Thomas, Morton A. Scheinberg, Ann Clarke, Cynthia Aranow, Frank R. Wellborne, Carlos Abud-Mendoza, Douglas R. Hough, Lilia Pineda, Thi-Sau Migone, Z. John Zhong, William W. Freimuth, W. Winn Chatham and on behalf of the BLISS-52 and BLISS-76 Study Groups

    Version of Record online : 26 JUN 2012, DOI: 10.1002/art.34400

  4. Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis

    Drug Development Research

    Volume 72, Issue 7, November 2011, Pages: 623–633, Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini and Graeme Jones

    Version of Record online : 23 NOV 2011, DOI: 10.1002/ddr.20472

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. Belimumab: A BLyS-Specific Inhibitor for the Treatment of Systemic Lupus Erythematosus

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 143–149, G J Dennis

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.290

  7. You have free access to this content
    Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus

    Arthritis Care & Research

    Volume 69, Issue 1, January 2017, Pages: 115–123, Luca Iaccarino, Silvano Bettio, Rossella Reggia, Margherita Zen, Micol Frassi, Laura Andreoli, Mariele Gatto, Silvia Piantoni, Linda Nalotto, Franco Franceschini, Maddalena Larosa, Micaela Fredi, Leonardo Punzi, Angela Tincani and Andrea Doria

    Version of Record online : 18 NOV 2016, DOI: 10.1002/acr.22971

  8. You have full text access to this OnlineOpen article
    Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two–Week Randomized, Double-Blind, Placebo-Controlled Study

    Arthritis & Rheumatology

    Volume 69, Issue 5, May 2017, Pages: 1016–1027, William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E. Hammer, Christi Kleoudis, James Groark, Damon Bass, Norma Lynn Fox, David Roth and David Gordon

    Version of Record online : 7 APR 2017, DOI: 10.1002/art.40049

  9. You have free access to this content
    Belimumab: targeted therapy for lupus

    International Journal of Rheumatic Diseases

    Volume 16, Issue 1, February 2013, Pages: 4–13, Preeta K. Chugh and Bhupinder S. Kalra

    Version of Record online : 19 OCT 2012, DOI: 10.1111/1756-185x.12002

  10. You have free access to this content
    BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus

    IUBMB Life

    Volume 64, Issue 7, July 2012, Pages: 595–602, Kirsten Fairfax, Ian R. Mackay and Fabienne Mackay

    Version of Record online : 29 MAY 2012, DOI: 10.1002/iub.1046

  11. You have free access to this content
    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 63, Issue 12, December 2011, Pages: 3918–3930, Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven and BLISS-76 Study Group

    Version of Record online : 29 NOV 2011, DOI: 10.1002/art.30613

  12. You have free access to this content
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

    Arthritis Care & Research

    Volume 61, Issue 9, 15 September 2009, Pages: 1168–1178, Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong and William W. Freimuth

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24699

  13. Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

    The Journal of Clinical Pharmacology

    Volume 53, Issue 7, July 2013, Pages: 711–720, Herbert Struemper, Cecil Chen and Wendy Cai

    Version of Record online : 16 MAY 2013, DOI: 10.1002/jcph.104

  14. Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects

    Clinical Pharmacology in Drug Development

    Volume 2, Issue 4, October 2013, Pages: 349–357, Wendy W. Cai, Michele Fiscella, Cecil Chen, Z. John Zhong, William W. Freimuth and David C. Subich

    Version of Record online : 26 AUG 2013, DOI: 10.1002/cpdd.54

  15. You have free access to this content
    Biologic agents in the treatment of glomerulonephritides

    Nephrology

    Volume 20, Issue 11, November 2015, Pages: 767–787, See Cheng Yeo and Adrian Liew

    Version of Record online : 7 OCT 2015, DOI: 10.1111/nep.12530

  16. The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 1, February 2014, Pages: 97–101, Y. Shida, N. Takahashi, T. Sakamoto, H. Ino, A. Endo and T. Hirama

    Version of Record online : 5 OCT 2013, DOI: 10.1111/jcpt.12101

  17. You have free access to this content
    Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study

    Arthritis & Rheumatism

    Volume 62, Issue 1, January 2010, Pages: 201–210, Annett M. Jacobi, Weiqing Huang, Tao Wang, William Freimuth, Inaki Sanz, Richard Furie, Meggan Mackay, Cynthia Aranow, Betty Diamond and Anne Davidson

    Version of Record online : 28 DEC 2009, DOI: 10.1002/art.27189

  18. Belimumab (Benlysta®)

    Handbook of Therapeutic Antibodies

    Pamela M. K Lutalo, Natasha Jordan, Thi-Sau Migone, David P. D'Cruz, Pages: 1405–1416, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch48

  19. You have free access to this content
    A23: Favorable Response to Belimumab in Childhood-Onset Systemic Lupus Erythematosus

    Arthritis & Rheumatology

    Volume 66, Issue S3, March 2014, Page: S37, Joyce S Hui-Yuen, Liza Mariel Bermudez-Santiago, Josephine Isgro, Andrew H. Eichenfield, Amy J. Starr, Lisa F. Imundo and Anca Askanase

    Version of Record online : 27 MAR 2014, DOI: 10.1002/art.38439

  20. You have full text access to this OnlineOpen article
    Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

    Arthritis & Rheumatology

    Volume 68, Issue 9, September 2016, Pages: 2184–2192, Ronald F. van Vollenhoven, Michelle Petri, Daniel J. Wallace, David A. Roth, Charles T. Molta, Anne E. Hammer, Yongqiang Tang and April Thompson

    Version of Record online : 25 AUG 2016, DOI: 10.1002/art.39682